Huiru An

<i><scp>NAT</scp>2</i> and <i><scp>CYP</scp>2<scp>E</scp>1</i> polymorphisms associated with antituberculosis drug‐induced hepatotoxicity in <scp>C</scp>hinese patients

Huiru An, Xueqiong Wu, Zhongyuan Wang et al. · Clinical and Experimental Pharmacology and Physiology · 2012 · 74 citations

Cytochrome P450 2E1, Genetics, Immunology +19

The relationship between absolute counts of lymphocyte subsets and clinical features in patients with pulmonary tuberculosis

Huiru An, Xue‐Juan Bai, Jianqin Liang et al. · The Clinical Respiratory Journal · 2022 · 33 citations · Full text

Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing

Qi Liu, Jingli Du, Huiru An et al. · Frontiers in Cellular and Infection Microbiology · 2023 · 31 citations · Full text

Polymorphisms in the Interleukin 18 Receptor 1 Gene and Tuberculosis Susceptibility among Chinese

Junxian Zhang, Zheng Li, Donglin Zhu et al. · PLoS ONE · 2014 · 25 citations · Full text

The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues

Wenping Gong, Huiru An, Jie Wang et al. · Frontiers in Immunology · 2022 · 17 citations · Full text

Bcg Vaccination, July 2022Sec, Immunology +25